FDA issues final guidance on adjusting for covariates in randomized clinical trials

[FDA]

This final guidance describes the agency’s current recommendations regarding adjusting for covariates in the statistical analysis of randomized clinical trials in drug and biological product development programs.


Baca selengkapnya di : http://www.fda.gov...